Literature DB >> 16686598

MT1-MMP hemopexin domain exchange with MT4-MMP blocks enzyme maturation and trafficking to the plasma membrane in MCF7 cells.

Susan J Atkinson1, Christian Roghi, Gillian Murphy.   

Abstract

The hemopexin-like domain of membrane-type matrix metalloproteinase-1 (MT1-MMP) enables MT1-MMP to form oligomers that facilitate the activation of pro-matrix metalloproteinase-2 (pro-MMP-2) at the cell surface. To investigate the role of the MT1-MMP hemopexin domain in the trafficking of MT1-MMP to the cell surface we have examined the activity of two MT1-MT4-MMP chimaeras in which the hemopexin domain of MT1-MMP has been replaced with that of human or mouse MT4-MMP. We show that MT1-MMP bearing the hemopexin domain of MT4-MMP was incapable of activating pro-MMP-2 or degrading gelatin in cell based assays. Furthermore, cell surface biotinylation and indirect immunofluorescence show that transiently expressed MT1-MT4-MMP chimaeras failed to reach the plasma membrane and were retained in the endoplasmic reticulum. Functional activity could be restored by replacing the MT4-MMP hemopexin domain with the wild-type MT1-MMP hemopexin domain. Subsequent analysis with an antibody specifically recognising the propeptide of MT1-MMP revealed that the propeptides of the MT1-MT4-MMP chimaeras failed to undergo proper processing. It has previously been suggested that the hemopexin domain of MT4-MMP could exert a regulatory mechanism that prevents MT4-MMP from activating pro-MMP-2. In this report, we demonstrate unambiguously that MT1-MT4-MMP chimaeras do not undergo normal trafficking and are not correctly processed to their fully active forms and, as a consequence, they are unable to activate pro-MMP-2 at the cell surface.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16686598      PMCID: PMC1525013          DOI: 10.1042/BJ20060243

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  TIMP-2 is required for efficient activation of proMMP-2 in vivo.

Authors:  Z Wang; R Juttermann; P D Soloway
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

3.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

4.  Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.

Authors:  W R English; X S Puente; J M Freije; V Knauper; A Amour; A Merryweather; C Lopez-Otin; G Murphy
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

5.  Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion.

Authors:  Y Itoh; A Takamura; N Ito; Y Maru; H Sato; N Suenaga; T Aoki; M Seiki
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

6.  Mutation analysis of membrane type-1 matrix metalloproteinase (MT1-MMP). The role of the cytoplasmic tail Cys(574), the active site Glu(240), and furin cleavage motifs in oligomerization, processing, and self-proteolysis of MT1-MMP expressed in breast carcinoma cells.

Authors:  D V Rozanov; E I Deryugina; B I Ratnikov; E Z Monosov; G N Marchenko; J P Quigley; A Y Strongin
Journal:  J Biol Chem       Date:  2001-05-02       Impact factor: 5.157

7.  Oligomerization through hemopexin and cytoplasmic domains regulates the activity and turnover of membrane-type 1 matrix metalloproteinase.

Authors:  Kaisa Lehti; Jouko Lohi; Minna M Juntunen; Duanqing Pei; Jorma Keski-Oja
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

8.  Membrane type I-matrix metalloproteinase (MT1-MMP) is internalised by two different pathways and is recycled to the cell surface.

Authors:  Albert Remacle; Gillian Murphy; Christian Roghi
Journal:  J Cell Sci       Date:  2003-08-12       Impact factor: 5.285

9.  Selective involvement of TIMP-2 in the second activational cleavage of pro-MMP-2: refinement of the pro-MMP-2 activation mechanism.

Authors:  Marc A Lafleur; Angus M Tester; Erik W Thompson
Journal:  FEBS Lett       Date:  2003-10-23       Impact factor: 4.124

10.  Dynamic association of cytoplasmic dynein heavy chain 1a with the Golgi apparatus and intermediate compartment.

Authors:  C Roghi; V J Allan
Journal:  J Cell Sci       Date:  1999-12       Impact factor: 5.285

View more
  6 in total

1.  Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys581 increases cellular invasion through type I collagen.

Authors:  Patricia A Eisenach; Pedro Corrêa de Sampaio; Gillian Murphy; Christian Roghi
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

2.  A role for MT1-MMP as a cell death sensor/effector through the regulation of endoplasmic reticulum stress in U87 glioblastoma cells.

Authors:  Sébastien Proulx-Bonneau; Jonathan Pratt; Borhane Annabi
Journal:  J Neurooncol       Date:  2010-11-19       Impact factor: 4.130

3.  Epigenetic control of the invasion-promoting MT1-MMP/MMP-2/TIMP-2 axis in cancer cells.

Authors:  Andrei V Chernov; Nor Eddine Sounni; Albert G Remacle; Alex Y Strongin
Journal:  J Biol Chem       Date:  2009-03-13       Impact factor: 5.157

4.  Molecular dissection of the structural machinery underlying the tissue-invasive activity of membrane type-1 matrix metalloproteinase.

Authors:  Xiao-Yan Li; Ichiro Ota; Ikuo Yana; Farideh Sabeh; Stephen J Weiss
Journal:  Mol Biol Cell       Date:  2008-05-21       Impact factor: 4.138

5.  Tracking the Cartoon mouse phenotype: Hemopexin domain-dependent regulation of MT1-MMP pericellular collagenolytic activity.

Authors:  Moustafa Sakr; Xiao-Yan Li; Farideh Sabeh; Tamar Y Feinberg; John J G Tesmer; Yi Tang; Stephen J Weiss
Journal:  J Biol Chem       Date:  2018-04-11       Impact factor: 5.157

6.  Functional analysis of a hypomorphic allele shows that MMP14 catalytic activity is the prime determinant of the Winchester syndrome phenotype.

Authors:  Ivo J H M de Vos; Evelyn Yaqiong Tao; Sheena Li Ming Ong; Julian L Goggi; Thomas Scerri; Gabrielle R Wilson; Chernis Guai Mun Low; Arnette Shi Wei Wong; Dominic Grussu; Alexander P A Stegmann; Michel van Geel; Renske Janssen; David J Amor; Melanie Bahlo; Norris R Dunn; Thomas J Carney; Paul J Lockhart; Barry J Coull; Maurice A M van Steensel
Journal:  Hum Mol Genet       Date:  2018-08-15       Impact factor: 6.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.